Deadline: 11-Dec-2025
The Alex’s Lemonade Stand Foundation is seeking applications for its Young Investigator Grant to support early career researchers, such as postdoctoral fellows, clinical fellows or instructors, pursuing promising childhood cancer research ideas.
The foundation is inviting proposals that align with its core mission to find better treatments and cures for pediatric cancer. Projects that focus solely or primarily on patients over the age of 19 will not be considered. The program encourages both translational and clinical research that can directly benefit children with cancer.
Researchers may request a budget of up to $180,000 in direct costs over a three-year period, with a maximum of $60,000 per year. Budgets must reflect the scale of the project and demonstrate appropriate use of funds. Cost-effectiveness and alignment with ALSF’s mission will be central to funding decisions.
Grantees will be required to submit annual progress reports that demonstrate satisfactory progress toward research objectives. Continued funding each year is contingent on these reports, along with appropriate use of the awarded budget. A minor carry-over of up to 25% is allowed with justification. However, if carry-over is found to be excessive, ALSF may withhold or reduce future funding.
At the end of the grant term, a final report must be submitted summarizing findings, use of funds, and any related publications or presentations. While the grant is not renewable, investigators may request a one-time no-cost extension to complete the project. Awardees will also be invited to attend the Young Investigator (YI) Summit, an event that fosters collaboration and knowledge sharing among pediatric cancer researchers.
All research outputs, including publications and presentations, are expected to acknowledge support from Alex’s Lemonade Stand Foundation and include the award number. This grant provides an important opportunity for scientists focused on childhood cancer to receive funding that supports meaningful, mission-aligned work with the potential for real patient impact.
For more information, visit ALSF.
